ArticleBMC infectious diseases2022
COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.
Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- Global COVID-19 vaccine acceptance rate: Systematic review and meta-analysis.Frontiers in public health · 2022Pooled it
- Effects of Scalable, Wordless, Short, Animated Storytelling Videos on Flu Vaccine Hesitancy in China: Nationwide, Single-Blind, Parallel-Group, Randomized Controlled Trial.Journal of medical Internet research · 2025Trial
- The syndemic nexus: How vaccine hesitancy and COVID-19 interact to influence vaccine uptake among university students.Human vaccines & immunotherapeutics · 2026Article
- Determinants and Dynamics of COVID-19 Vaccine Hesitancy in University Students: A Machine Learning Analysis.Vaccines · 2026Article
- Assessing psychological antecedents of vaccination in family health center visitors.Primary health care research & development · 2026Article
- Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic.Frontiers in health services · 2026Review
- COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting.Human vaccines & immunotherapeutics · 2025Article
- Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study.BMC public health · 2025Article
- Exploring healthcare workers' immunisation behaviour towards COVID-19 vaccines through psychological patterns.African journal of primary health care & family medicine · 2025Article
- Association between COVID-19 anxiety syndrome and COVID-19 vaccine hesitancy in the postpandemic era: a cross-sectional study in Hong Kong.BMC public health · 2025Article
- Understanding vaccine hesitancy through the lens of trust and the 3C model: evidence from Chinese General Social Survey 2021.Frontiers in public health · 2025Article
- A qualitative examination of the distribution strategies, access, and equitable uptake of the COVID-19 vaccines in Kenya: lessons for the next pandemic.Frontiers in public health · 2025Article
- COVID-19 vaccination and concerns regarding vaccine hesitancy after the termination of the zero-COVID policy in China: A nationwide cross-sectional study.Human vaccines & immunotherapeutics · 2024Article
- COVID-19 vaccine hesitancy in Ethiopia: a latent class analysis.BMC public health · 2024Article
- A Comprehensive Analysis of COVID-19 Misinformation, Public Health Impacts, and Communication Strategies: Scoping Review.Journal of medical Internet research · 2024Article
- The relationship between vaccine hesitancy and health literacy in pregnant women: a cross-sectional study.BMC women's health · 2024Article
- Parental hesitancy toward children vaccination: a multi-country psychometric and predictive study.BMC public health · 2024Observational
- Pediatric asthma and COVID-19 vaccination: unveiling patterns of hesitancy and acceptance.Therapeutic advances in vaccines and immunotherapy · 2024Article
- Readiness for influenza and COVID-19 vaccination in Germany: a comparative analysis.Frontiers in psychology · 2024Article
- COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.Human vaccines & immunotherapeutics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 8 institutions in 1 country.
Funding
Abstract
backgroundCOVID-19 vaccine has been available in China since the beginning of the 2021, however, certain numbers of people are reluctant for some reasons to vaccinate. The high vaccine coverage is crucial for controlling disease transmission, however, the vaccine hesitancy might be a barrier to the establishment of sufficient herd immunization. This study aims to investigate the prevalence of the COVID-19 vaccine hesitancy among different population groups, and explore common barriers and facilitators to vaccination decisions.
methodsThe current survey was performed among Chinese students, public health professionals, medical workers and general population from January to March 2021 from seven cities in China. The questionnaire contained sociodemographic information, concerns about infection with COVID-19, general vaccination behaviors and attitudes, the General Vaccine Hesitancy Scale, the COVID-19 Vaccine Hesitancy Scale and other potential factors. Univariate analysis was conducted by chi-squared test, and variables significant at P < 0.10 were then included in a multivariable regression model.
resultsThe prevalence of COVID-19 vaccine hesitancy was 15.6% in our study, and 23.9% of students, 21.2% of the general population, 13.1% of medical workers, and 10.4% of public health professionals had vaccine hesitancy. The results of multivariate analysis indicated that participants who had received negative information of COVID-19 vaccine (OR: 1.563, 95% CI: 1.229-1.986) and who had doubts about the information source (OR: 2.157, 95% CI: 1.697-2.742) were more likely to have vaccine hesitancy. While those who needed transparent information about COVID-19 vaccine (OR: 0.722, 95% CI: 0.535-0.973) and who would get COVID-19 vaccine if doctors recommended (OR: 0.176, 95% CI: 0.132-0.234) were less likely to have COVID-19 vaccine hesitancy.
conclusionsGiven recommendations from medical workers about vaccination can motivate people to accept COVID-19 vaccination, appropriate training in knowledge about vaccines and communication skills are necessary for them to increase public's willingness of vaccination. Reducing the spread of misinformation and disseminating facts in a timely and accurate way will likely reduce vaccine hesitancy. Moreover, to establish suitable communication strategies and information exchange platforms between the government and the public and a warning system on infodemic would be helpful to improve public's confidence in vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.